回首頁 到查詢結果 [ subject:"Embryonic stem cells" ]

Regulating human embryonic stem cell...
Jiang, Li.

 

  • Regulating human embryonic stem cell in China[electronic resource] :a comparative study on human embryonic stem cell's patentability and morality in US and EU /
  • 紀錄類型: 書目-電子資源 : Monograph/item
    杜威分類號: 344.5104196
    書名/作者: Regulating human embryonic stem cell in China : a comparative study on human embryonic stem cell's patentability and morality in US and EU // by Li Jiang.
    作者: Jiang, Li.
    出版者: Singapore : : Springer Singapore :, 2016.
    面頁冊數: xviii, 200 p. : : ill., digital ;; 24 cm.
    Contained By: Springer eBooks
    標題: Embryonic stem cells - Research - China.
    標題: Embryonic stem cells - Research - European Union countries.
    標題: Embryonic stem cells - Research - United States.
    標題: Law.
    標題: Medical Law.
    標題: International IT and Media Law, Intellectual Property Law.
    標題: Bioethics.
    ISBN: 9789811021015
    ISBN: 9789811021008
    內容註: Values of Human Embryonic Stem Cell Research, the phenomenon of "Stem Cell Tourism" and Inadequate regulation of Human Embryonic Stem Cell in China -- The Moral Maze In Human Embryonic Stem Cell Research: the moral status of human embryo and the moral source of human embryonic stem cell -- China: inconsistent moral standards of human embryonic stem cell research between patent law and practical application -- The United States: Inconsistent policies on federal funding control of human embryonic stem cell research -- The European Union: Inconsistent interpretations of moral provisions in Patent Convention addressing human embryonic stem cell research -- A proposal for controlling human embryonic stem cell research in China: regulate research itself in a reconciled human embryonic stem cell regulation at the international regime.
    摘要、提要註: The general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China. The book highlights that both patent control and federal control are inefficient and ineffective way to monitoring human embryonic stem cell research. The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime. The potential reader includes academics and practitioners dealing with intellectual property, patent law and stem cell inventions. The topic discussed will also be interesting to a broad readership, including experts, regulators, policy makers and medical researchers in both ethical and legal disciplines in the field of embryonic stem cell research.
    電子資源: http://dx.doi.org/10.1007/978-981-10-2101-5
評論
Export
取書館別
 
 
變更密碼
登入